Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10Pain, Postoperative 9Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Lung Neoplasms 8Stomach Neoplasms 6Colonic Neoplasms 6Brain Neoplasms 6Thyroid Neoplasms 5Prostatic Neoplasms 5Colorectal Neoplasms 5Agnosia 4Thromboembolism 3Pain 3Ovarian Neoplasms 3Myofibroma 3Head and Neck Neoplasms 3Depression 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Supratentorial Neoplasms 2Neoplasm Metastasis 2Leiomyoma 2Hemangioma 2Arthritis, Rheumatoid 2Vomiting 1Visceral Pain 1Uterine Cervical Neoplasms 1

Interventions

Vasopressins 1Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1Saline Solution 1Norepinephrine 1Methylene Blue 1Contraceptives, Oral 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Shock, Septic × Saline Solution × Clear all
NCT06005558 2024-07-05

Low Dose Versus High Dose Methylene Blue in Septic Patients

National Cancer Institute, Egypt

Phase 2/3 Completed
90 enrolled

Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡